# Reducing Cardiac-surgery Associated Acute Kidney Injury Occurence by Administering Angiotensin II

> **NCT06615102** · PHASE3 · RECRUITING · sponsor: **Universität Münster** · enrollment: 1022 (estimated)

## Conditions studied

- Cardiac Surgery
- Vasoplegia

## Interventions

- **DRUG:** Angiotensin II
- **DRUG:** Noradrenalin

## Key facts

- **NCT ID:** NCT06615102
- **Lead sponsor:** Universität Münster
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-31
- **Primary completion:** 2027-01
- **Final completion:** 2027-04
- **Target enrollment:** 1022 (ESTIMATED)
- **Last updated:** 2025-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06615102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06615102, "Reducing Cardiac-surgery Associated Acute Kidney Injury Occurence by Administering Angiotensin II". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06615102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*